Bioorganic and Medicinal Chemistry Letters p. 2677 - 2682 (1996)
Update date:2022-08-02
Topics:
Friesen, Richard W.
Dube, Daniel
Fortin, Rejean
Frenette, Richard
Prescott, Sylvie
Cromlish, Wanda
Greig, Gillian M.
Kargman, Stacia
Wong, Elizabeth
Chan, Chi Chung
Gordon, Robert
Xu, Li Jing
Riendeau, Denis
A series of novel 2,3-diaryl-2-cyclobuten-1-ones have been synthesized and have been evaluated with respect to their ability to inhibit the isozymes of cyclooxygenase, COX-1 and COX-2. 4,4-Dimethyl-2-phenyl-3-[4-(methylsulfonyl)phenyl]cyclobutenone 22 was found to be highly selective for inhibition of COX-2 and was orally active (ED50 = 2.4 mg/kg) in the rat paw edema model.
View MoreShanxi Tongji Pharmaceuticals Co., Ltd.
Contact:+86-359-3024784
Address:Xikuang South Road, Ruicheng County , Shanxi
Suzhou Tianma Specialty Chemicals Co.,Ltd
Contact:+86-512-68090577
Address:#199, Huayuan Rd, Mudu, Suzhou, Jiangsu, CHINA
Shandong Yuanli Science and Technology Co., Ltd.
Contact:86-0536-6777557
Address:Zhuliu Industiral Park,Changle County
Shandong Jiulong Hisince Pharmaceutical Co.,Ltd.
Contact:+86-15853188990
Address:Huadian Pioneer Park, Huadian Township, Qihe County, Dezhou City, Shandong, P.R.China
Sinoway International (Jiangsu) Co., Ltd.
Contact:+86-25-86630167
Address:17 Beijing Road (West), Nanjing, China
Doi:10.1016/S0960-894X(96)00561-6
(1996)Doi:10.1002/cctc.201601654
(2017)Doi:10.1002/anie.199701551
(1997)Doi:10.1016/S0040-4039(96)02196-X
(1997)Doi:10.1002/chem.19970031006
(1997)Doi:10.3797/scipharm.aut-04-02
(2004)
